Dillon C Perryman is a pharmacist who is specialized in Psychiatric in Memphis, Tennessee. Patients can reach him at 1030 Jefferson Ave, Memphis or contact him on 901-523-8990. Active license number of Dillon C Perryman is 6303 for Psychiatric in North Dakota. Dillon C Perryman is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Complete Profile:
Dillon C Perryman speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Dillon C Perryman
Specialization:
Psychiatric
Gender:
Male
Location:
1030 Jefferson Ave, Memphis, Tennessee, 38104-2127
Phone:
901-523-8990
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dillon C Perryman are as mentioned below.
NPI Number:
1710650387
NPI Enumeration Date:
29 Jul, 2021
NPI Last Update On:
29 Sep, 2025
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dillon C Perryman are as mentioned below.
Specialization
License Number
State
Status
Psychiatric
6303
North Dakota
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1030 Jefferson Ave, Memphis, Tennessee
Zip:
38104-2127
Phone Number:
901-523-8990
Fax Number:
--
Patients can reach Dillon C Perryman at 1030 Jefferson Ave, Memphis, Tennessee or can call on phone at 901-523-8990.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.